Klebsiella pneumoniae
Multiresistance per hospital
(% resistance to ceftazidime, ciprofloxacin and
tobramycin)
All clinical specimens
(July - December 2015)
Hospital | Medical Wards |
Surgical Wards |
ICU |
||||||||
%kpn/total isolates |
Isolates Tested |
%R |
%kpn/total isolates |
Isolates Tested |
%R |
%kpn/total isolates |
Isolates Tested |
%R |
|||
GR007 | 11,3% |
18 |
38,9 |
9,7% |
11 |
45,5 |
14,2% |
30 |
93,3 |
||
GR011* | 8,6% |
57 |
5,3 |
8,0% |
11 |
9,1 |
10,3% |
9 |
0,0 |
||
GR013 | 14,8% |
39 |
25,6 |
10,2% |
13 |
46,2 |
15,0% |
16 |
87,5 |
||
GR014 | 12,0% |
172 |
39,5 |
8,3% |
46 |
65,2 |
14,5% |
70 |
77,1 |
||
GR018 | 8,2% |
4 |
8,8% |
2 |
|||||||
GR026 | 6,3% |
17 |
11,8 |
2,7% |
6 |
||||||
GR030 | 9,7% |
33 |
48,5 |
13,4% |
11 |
36,4 |
14,0% |
16 |
62,5 |
||
GR032 | 11,7% |
20 |
35,0 |
8,6% |
7 |
0,0 |
12,3% |
3 |
|||
GR037 | 11,7% |
46 |
28,3 |
13,8% |
11 |
45,5 |
13,6% |
3 |
|||
GR039 | 11,6% |
7 |
42,9 |
9,6% |
4 |
8,8% |
2 |
||||
GR040 | 14,3% |
109 |
45,0 |
11,3% |
41 |
43,9 |
14,5% |
22 |
72,7 |
||
GR041 | 10,8% |
115 |
47,0 |
7,6% |
34 |
64,7 |
16,9% |
27 |
81,5 |
||
GR042 | 12,1% |
27 |
11,1 |
10,8% |
8 |
12,5 |
|||||
GR043 | 18,9% |
159 |
38,4 |
29,4% |
14 |
35,7 |
28,3% |
54 |
64,8 |
||
GR047 | 18,3% |
195 |
36,4 |
17,0% |
121 |
37,2 |
19,0% |
15 |
80,0 |
||
GR048 | 1,4% |
1 |
10,3% |
9 |
11,1 |
11,8% |
3 |
||||
GR051 | 10,4% |
34 |
23,5 |
6,3% |
10 |
40,0 |
21,7% |
2 |
|||
GR056 | 14,7% |
20 |
45,0 |
7,6% |
6 |
10,3% |
4 |
||||
GR062 | 5,0% |
34 |
29,4 |
2,1% |
4 |
2,7% |
4 |
||||
GR068 | 15,2% |
15 |
46,7 |
9,3% |
46 |
28,3 |
19,5% |
29 |
82,8 |
||
GR070 | 12,5% |
110 |
30,0 |
12,6% |
54 |
37,0 |
14,8% |
23 |
65,2 |
||
GR076 | 11,0% |
190 |
28,4 |
11,9% |
88 |
34,1 |
17,9% |
16 |
25,0 |
||
Weighted Average | 13,2% |
1422 |
34,4 |
11,7% |
557 |
39,1 |
16,2% |
348 |
70,1 |
||
Hospital Mean | 32,8 |
34,8 |
66,0 |